Compounded tirzepatide vial

Rx

Compounded Tirzepatide

  • Dual-receptor.

  • Weekly injection.

  • A licensed provider in your corner.

Start Your Assessment
See Important Safety Information ↓

  • Compounded tirzepatide is not an FDA-approved drug product. It is prepared by a licensed compounding pharmacy and requires a valid prescription from a licensed healthcare provider. Individual results vary. Not all patients will be eligible for treatment. Speak with your provider about the risks and benefits specific to your health history.

  • If you experience symptoms of a serious allergic reaction, pancreatitis, or vision changes, contact a healthcare provider immediately or call 911.

GLP-1 medications are prescription-only. A licensed healthcare provider must review your health intake assessment before any prescription is issued. Prescription issuance is not guaranteed and is solely at the discretion of the reviewing provider based on your individual health history and clinical criteria.

Prescription required. A licensed provider will review your information before any medication is prescribed. Results may vary. Individual results are not guaranteed. Telehealth is not appropriate for all medical conditions. If you are experiencing an emergency, call 911.

What You Get with One Reserve

Prescription-based weight loss care, reviewed by a licensed medical provider.

  • Health assessment reviewed by a licensed provider

  • Prescription — where clinically appropriate

  • Medication compounded and shipped by a licensed pharmacy

  • Ongoing provider check-ins and dose adjustments

  • Access to your care team through the secure patient portal

Start Your Assessment

The Science

What Tirzepatide Does in Your Body

Tirzepatide activates two receptors — GLP-1 and GIP — instead of one. GLP-1 reduces appetite and slows digestion. GIP works alongside it to enhance insulin sensitivity and reinforce appetite regulation through a complementary pathway.

Your provider determines whether tirzepatide or semaglutide is the right clinical choice for your specific case.

This is not an upgrade you self-select. It’s a clinical determination. That’s what makes it real care.

Administered as a weekly subcutaneous (under-the-skin) injection. Dose is started low and titrated upward by your provider based on your tolerance and response.

  • Complete your health assessment. Answer focused questions about your health history, current weight, and goals online.
  • A licensed provider reviews your intake and determines whether compounded tirzepatide is clinically appropriate. A real clinical review, not a checkbox.
  • If eligible, a prescription is issued and sent to a licensed compounding pharmacy for fulfillment.
  • Medication ships discreetly to your door. Your provider monitors your progress and adjusts dosing over time.

Compounded formulations of semaglutide and tirzepatide are not FDA-approved drug products. The FDA has approved semaglutide and tirzepatide as active pharmaceutical ingredients in specific branded prescription products. Compounded versions are prepared by state-licensed 503A or 503B compounding pharmacies and are not FDA-approved finished drug products. They are not interchangeable with FDA-approved branded formulations. Results may vary. Individual results are not guaranteed.

Questions People Actually Ask

View all FAQs →

One Life. One Body. Reserve It.

The future of health is here. You either act on it or you don’t. One Reserve is for people who act.

Start Your Assessment

Prescription issuance is not guaranteed and is solely at the discretion of the reviewing provider.